Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Dill

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|December 14, 2011
Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patientsKatharina Baur, Joachim C Mertens, Johannes Schmitt, et al.
BMJ Open|September 10, 2025
Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)Conrad Rauber, Maria Paula Roberti, Maria Jgt Vehreschild, et al.
Hepatology (Baltimore, Md.)|July 16, 2015
YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factorsPatricia Marti, Claudia Stein, Tanja Blumer, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2025
Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real-World Analysis of the IMMUreal CohortNajib Ben Khaled, Valentina Zarka, Bernard Hobeika, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 6, 2026
Strawberry Notch 1 Acts as a Transcriptional Regulator Driving Oncogenic Programs in Liver CarcinogenesisSarah Fritzsche, Raisatun Nisa Sugiyanto, Kira Gür, et al.
JHEP Reports : Innovation in Hepatology|May 13, 2024
Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trialPhilipp Hoegen-Saßmannshausen, Patrick Naumann, Paula Hoffmeister-Wittmann, et al.
United European Gastroenterology Journal|September 20, 2024
Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohortKatharina Mitzlaff, Martha M Kirstein, Christian Müller, et al.
Journal of Hepatology|April 19, 2026
Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitisPeder R Braadland, Ahmad H Ali, Philip Puchas, et al.
Cell Reports|November 1, 2018
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in CancerYumeng Wang, Xiaoyan Xu, Dejan Maglic, et al.
Science Advances|April 1, 2026
Hepatitis E virus replication is maintained in proliferative cells within the intestinal cryptSarah Prallet, Niclas Maier, Albert Li, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Liver International : Official Journal of the International Association for the Study of the Liver|December 14, 2011
Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patientsKatharina Baur, Joachim C Mertens, Johannes Schmitt, et al.
BMJ Open|September 10, 2025
Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)Conrad Rauber, Maria Paula Roberti, Maria Jgt Vehreschild, et al.
Hepatology (Baltimore, Md.)|July 16, 2015
YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factorsPatricia Marti, Claudia Stein, Tanja Blumer, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2025
Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real-World Analysis of the IMMUreal CohortNajib Ben Khaled, Valentina Zarka, Bernard Hobeika, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 6, 2026
Strawberry Notch 1 Acts as a Transcriptional Regulator Driving Oncogenic Programs in Liver CarcinogenesisSarah Fritzsche, Raisatun Nisa Sugiyanto, Kira Gür, et al.
JHEP Reports : Innovation in Hepatology|May 13, 2024
Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trialPhilipp Hoegen-Saßmannshausen, Patrick Naumann, Paula Hoffmeister-Wittmann, et al.
United European Gastroenterology Journal|September 20, 2024
Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohortKatharina Mitzlaff, Martha M Kirstein, Christian Müller, et al.
Journal of Hepatology|April 19, 2026
Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitisPeder R Braadland, Ahmad H Ali, Philip Puchas, et al.
Cell Reports|November 1, 2018
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in CancerYumeng Wang, Xiaoyan Xu, Dejan Maglic, et al.
Science Advances|April 1, 2026
Hepatitis E virus replication is maintained in proliferative cells within the intestinal cryptSarah Prallet, Niclas Maier, Albert Li, et al.
Pageof 5